Biotech Dendreon files for Chapter 11 to restructure massive debts -...

11/10/14

Biotech Dendreon files for Chapter 11 to restructure massive debts
The Seattle Times
The biotechnology company, once Seattle's largest, said it filed a voluntary Chapter 11 bankruptcy petition in Delaware, where it was early on Nov. 10. Dendreon, which pioneered a therapy for treating prostate cancer with boosted cells from a patients ...